Health Care & Life Sciences » Biotechnology | Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.11
Market Cap
$775.58 M
Shares Outstanding
63.78 M
Public Float
46.37 M

Profile

Address
1035 O'Brien Drive
Menlo Park California 94025
United States
Employees -
Website http://www.adverum.com
Updated 07/08/2019
Adverum Biotechnologies, Inc. is a clinical-stage biotechnology company that engages in the development of novel gene therapies to treat patients with sight-threatening ophthalmic diseases. It focuses on treatment of wet age-related macular degeneration, alpha-1 antitrypsin deficiency, hereditary angioedema, friedreich's ataxia, severe allergy, color vision deficiency, and juvenile x-linked retinoschisis. The company was founded by Mark S.

Financials

View All

Paul B. Cleveland
Chairman
Mitchell H. Finer
Director